BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23030270)

  • 1. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH; Patel HH; Donahue E; Patel AD
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
    Dave RH; Patel AD; Donahue E; Patel HH
    Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of colloidal solid dispersions: physiochemical considerations and in vitro release profile.
    Patel VI; Dave RH
    AAPS PharmSciTech; 2013 Jun; 14(2):620-8. PubMed ID: 23494469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated.
    de Waard H; Hinrichs WL; Visser MR; Bologna C; Frijlink HW
    Int J Pharm; 2008 Feb; 349(1-2):66-73. PubMed ID: 17804180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
    Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
    Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion.
    Patel AR; Joshi VY
    AAPS PharmSciTech; 2008; 9(2):583-90. PubMed ID: 18459049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cogrinding with various kinds of surfactants on the dissolution behavior of phenytoin.
    Otsuka M; Matsuda Y
    J Pharm Sci; 1995 Dec; 84(12):1434-7. PubMed ID: 8748325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation and in vivo performance of lyophilized gliclazide.
    Mansour HF; Aly UF
    Drug Dev Ind Pharm; 2015 Apr; 41(4):650-7. PubMed ID: 24568609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and physicochemical characterization of binary and ternary ground mixtures of carvedilol with PVP and SLS aimed to improve the drug dissolution.
    Bolourchian N; Talamkhani Z; Nokhodchi A
    Pharm Dev Technol; 2019 Nov; 24(9):1115-1124. PubMed ID: 31282827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
    Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
    Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant-mediated dissolution of metformin hydrochloride tablets: wetting effects versus ion pairs diffusivity.
    Desai D; Wong B; Huang Y; Ye Q; Tang D; Guo H; Huang M; Timmins P
    J Pharm Sci; 2014 Mar; 103(3):920-6. PubMed ID: 24549733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
    Moes JJ; Koolen SL; Huitema AD; Schellens JH; Beijnen JH; Nuijen B
    Int J Pharm; 2011 Nov; 420(2):244-50. PubMed ID: 21907780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.